Navigation Links
New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
Date:9/12/2007

FRIMLEY, England, September 13 /PRNewswire-FirstCall/ --

- Physicians Welcome New Option for Potentially Life Threatening Disease

- Daptomycin has a Rapidly Bactericidal Mode of Action

The launch of daptomycin for the treatment of both methicillin-sensitive and resistant Staphylococcus aureus (MSSA and MRSA) bloodstream infections (bacteraemia) and heart infections (right-sided infective endocarditis) has been announced today by Novartis Pharmaceuticals UK Ltd.(1) Daptomycin, one of only two new classes of antibiotic in over 20 years, has been shown to be as effective as existing agents in treating a range of serious Gram-positive infections, offering an important new option for healthcare professionals.

MRSA is a frequent cause of bacteraemia and is associated with serious complications, including endocarditis (in 30-40% of cases) and has a high mortality rate.(2) Over 7,000 people each year contract bacteraemia and the incidence is rising.(3) From 1993 to 2005 the number of deaths increased from 51 to 1,629.(4) There is evidence that some strains of MRSA are developing resistance to existing antibiotic options.(5) Daptomycin, which is rapidly bactericidal, has a specific mode of action, which reduces the likelihood of resistance developing. Daptomycin's once daily dosing and tolerability profile, with no need for therapeutic drug monitoring, has the potential to simplify the management of patients with complicated infections.

Dr Andrew Seaton, consultant in infectious diseases, Gartnavel general hospital, Glasgow welcomed the news, commenting; "Serious staphylococcal infections are extremely challenging for hospital specialists to treat, with about 40% in the UK now resistant to first line therapy. Daptomycin is a fast acting agent in these potentially difficult situations and is well tolerated by patients. This is an extremely important and welcomed development in the battle against serious MRSA infection."

Daptomycin is
'/>"/>

SOURCE Novartis Pharmaceuticals UK Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...if., Nov. 6 Calbiotech, Inc. annou...ss Innovative Research (SBIR) Phase I contract by ...d. Under terms of the agreement, Calbiotech will d...agnosis of Dengue virus. ,, Dengue virus is ... threat to military forces deployed to tropical ar...
(Date:11/6/2009)...ov. 6 Intarcia Therapeutics, Inc. ...(DUROS® continuous delivery of exenatide) pro...inth Annual Diabetes Technology Meeting in San Fra...gi-bin/prnh/20050301/SFTU126LOGO ) ,, Continu...0 Lowers Plasma Glucose, HbA1c and Reduces Weight ...
(Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
(Date:11/5/2009)... Nov. 5 The endangered black-foote... U.S. This rare carnivore feeds on prairie dogs. ...and often entire population die-offs in towns occu... implemented a ferret breeding program and has bee...rmerly native habitat. Unfortunately, plague can ...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...e/ - The acceptance of Peros, oral,delivery platfo...significant achievement by Benchmark Biolabs, a fu...irm., Benchmark Biolabs designed, constructed and...s production facility which is co-located on,Bench...in Lincoln, NE., By obtaining approval by the USD...
...il 15 diaDexus, Inc.,today announced the appointm... channel for its new automated PLAC Test for the H...try analyzers to U.S. hospital clinical,laboratori...by the U.S.,Food & Drug Administration (FDA) enabl...istry analyzers., The PLAC Test is the only blood...
...ally enable access to MRI exams for ...ass. and BALTIMORE, April 15 Boston,Scientific Co...privately held,company, today announced a licensin...ce imaging (MRI)-safe technology. Physician implan...devices as a primary unmet clinical,need. Under th...
Other Biology Technology:Another industry first enabled by Benchmark Biolabs - Peros' oral delivery platform and vaccine facility licensed by the USDA 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 2Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 3
(Date:11/6/2009)...Monell Center and the Chinese Academy of Sciences ...eting on Taste and Smell Research. Organized by Mo...ll be the first international meeting on taste and...f Executive Officer, American Association for the ...Science magazine, will open the meeting with a ple...
(Date:11/4/2009)...reluctant to officially endorse green tea as a can...about its protective effects, including results of...rch , a journal of the American Association for Ca...al cancer. , Vassiliki Papadimitrakopoulo, M.D....cic/Head and Neck Medical Oncology at the Universi...
(Date:11/4/2009)...ns out, hold the power to help militaries and muni...up toxic waste on test sites. , Compounds known ...k in World War II and have been used in military m... are often used to propel tank shells and act like...creased knowledge of their environmentally harmful...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2Women underrepresented in most cancer research 48173 1Women underrepresented in most cancer research 48173 2Women underrepresented in most cancer research 48173 3Women underrepresented in most cancer research 48173 4ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 1ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 2ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 3Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3
...the second call for proposals, projects focus on e...e interface between biomedical research and genomi...pproved six RTD-projects today. They will engage a...al Institutes of Technology (ETH Zurich und EPF La..., Lausanne, Geneva and Zurich. The Friedrich-Miesc...
...oup of researchers from the LGC Chemical Metrology...ty of Oviedo, Spain, have come up with a method to...cal element (atoms with an equal number of protons...vary throughout the length of a single hair. The m...ds to track the geographical movements of people, ...
... Rochelle, NY, May 27, 2009New guidelines designed...ent, and monitoring of patients with Medullary Thy...form of thyroid cancer, have been developed by the... ahead of print in Thyroid , a peer-reviewed jour...ertpub.com ). The guidelines are available free on...
Other Biology News:Swiss Initiative in Systems Biology launches new projects 2Sulphur in just one hair could blow a terrorist's alibi 2Sulphur in just one hair could blow a terrorist's alibi 3First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2
Mouse Anti-Bovine GTP BINDING PROTEIN Monoclonal Antibody, Unconjugated, Clone 1H6 from AbD Serotec
... E. coli containing a clone of the human Topoisome...ters the topological state of nucleic acids by pas... which generates a separate DNA helix (1,2) . As a...sm, the enzyme can relax negatively or positively ...
...ral Stem Cell Expansion Kit - Monolayer is a syste...ayer in a serum-free environment. The kit contains... which has been optimized for neural stem cell exp...ment 10 :3129). Human fibroblast growth factor ba...
AMV Reverse Transcriptase from Promega
Biology Products: